Yomi Pharma
PrivateLast Round
Seed
Oct 3, 2025
Est. Valuation
$7.19M
Total Funding Raised
$1.48M
Company Overview
Yomi Pharma is a biotechnology company that develops targeted therapies for resistant lung cancer by exploiting the properties of the sortilin protein.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Yomi Pharma Comparables
Compare Yomi Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Apmonia Therapeutics | 77% | |
| Sortina Pharma | 77% | |
| PEP-Therapy | 70% | |
Yomi Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 3, 2025 | ||||
| Grant | Jan 1, 2025 |
Yomi Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Région Nouvelle-Aquitaine | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2025
$107K grant from Région Nouvelle-Aquitaine
Yomi Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Yomi Pharma's valuation, stock price, and market status.